Testing effectiveness (Phase 2)Study completedNCT01532700
What this trial is testing
An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University Health Network, Toronto 28